Newsroom

Keep up with our latest news.

June 2021

Caris Life Sciences and Elevation Oncology Announce Joint Discovery and Development Collaboration Focused on Oncogenic Fusions and Driver Mutations

All
Press Releases

June 24, 2021

Press Releases

Elevation Oncology Announces Pricing of Initial Public Offering Read More

June 17, 2021

Press Releases

Elevation Oncology Announces Appointment of Joseph Ferra as Chief Financial Officer Read More

June 15, 2021

Press Releases

Caris Life Sciences and Elevation Oncology Announce Joint Discovery and Development Collaboration Focused on Oncogenic Fusions and Driver Mutations Read More

May 18, 2021

Press Releases

Elevation Oncology Appoints Michael Carruthers to Board of Directors and Chair of the Audit Committee Read More

April 10, 2021

Press Releases

Elevation Oncology Announces the Presentation of New Preclinical Data in Pancreatic and Cholangiocarcinoma PDX Models on the Specific Inhibition of HER3 with Seribantumab to Block NRG1 Fusion Signaling Read More

April 06, 2021

Press Releases

Elevation Oncology Announces Clinical Cancer Research Publication Highlighting the Specific Inhibition of HER3 by Seribantumab in Preclinical NRG1 Fusion Models Read More

Pages: 123Last Page

Investor Resources

Follow our journey with our latest Investor Resources

Press Releases

Read the latest News Releases for Investors

Events

Browse the calendar to view Investor related events and announcements. Webcasts and presentations that have been archived are available by viewing historical event details.

SEC Filings

Review all of Elevation's SEC filings

Track our progress

Check back often for our latest insights, or sign up for our mailing list to receive the have the latest news and publications from Elevation Oncology delivered to your inbox.